Category: Multiple Sclerosis (MS)
Global Multiple Sclerosis (MS)
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Medical Exoskeleton Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others), and Geography
... Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare ... Read More
-
Intermittent Catheters Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Coated Intermittent Catheters and Uncoated Intermittent Catheters), Indication [Urinary Incontinence, General Surgeries, Spinal Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Cord Injuries, Parkinson’s Disease (PD), Multiple Sclerosis, and Others], Category (Female Length Catheters, Male Length Catheters, and Kid Length Catheters), System Type (Closed Intermittent Catheters Systems and Open Intermittent Catheters Systems), End User (Hospitals, Ambulatory ... Read More
-
Multiple Sclerosis Therapeutics Market - 2024-2031
... forecast period 2024-2031. Multiple sclerosis (MS) is an autoimmune condition that affects the brain and spinal cord (central nervous system). With MS, the immune system mistakenly attacks myelin cells. These are the protective covers (sheaths) ... Read More
-
Multiple Sclerosis Therapeutics
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Immunomodulators, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$13.2 Billion by the ... Read More
-
Multiple Sclerosis Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 21.33 billion in 2023, and the market is now projected to grow from USD 21.16 billion in 2024 to USD 38.94 billion by 2032, exhibiting a CAGR of 7.9% during the forecast ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Global Autoinjectors Market Size study & Forecast, by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User (Home Care Settings, Hospital and Clinics, and Others), and Regional Analysis, 2023-2030
... 2023-2030 Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices ... Read More
-
Injectable Cytotoxic Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 18.29 billion in 2023, and the market is now projected to grow from USD 19.03 billion in 2024 to USD 30.85 billion by 2032, exhibiting a CAGR of 6.2% during the forecast ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Anti-inflammatory Therapeutics Market Size, Trends, Analysis, and Outlook By Drug Class (Nonsteroidal Anti-inflammatory Diseases (NSAIDs), Corticosteroids, Biologics), By Indication (Arthritis, Respiratory Disease, Multiple Sclerosis, Psoriasis, Anti-inflammatory Bowel Disease (IBD), Others), by Region, Country, Segment, and Companies, 2024-2030
... Companies, 2024-2030 The global Anti-inflammatory Therapeutics market size is poised to register 6.24% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Cytotoxic Drugs Market – By Type (Branded, Generic), Drug Class (Alkylating Agents, Antimetabolites, Antitumor Antibiotics, Plant Alkaloids), Route of Administration (Oral, Parenteral), Application (Oncology, Multiple Sclerosis), Distribution Channel – Global Forecast 2024 – 2032
... Drugs Market size is estimated to depict 5.4% CAGR between 2024 and 2032. The increasing incidence of cancer worldwide is fueling the demand for cytotoxic drugs as primary or adjunctive therapies. According to WHO, in ... Read More
-
Specialty Generics Market Size, Trends, Analysis, and Outlook By Type (Injectables, Oral drugs, Others), By Application (Oncology, Inflammatory conditions, Multiple sclerosis, Hepatitis C, Others), By End-user (Specialty pharmacy, Retail pharmacy, Hospital pharmacy), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global Specialty Generics market size is poised to register 11.48% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the ... Read More
-
Magnetoencephalography Market Size, Trends, Analysis, and Outlook By Application (Clinical (Dementia, Autism, Schizophrenia,-Multiple Sclerosis, Stroke, Epilepsy), Research), By End-user (Hospitals, Imaging centers, Academic and research institutes), by Region, Country, Segment, and Companies, 2024-2030
... Magnetoencephalography market size is poised to register 4.94% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Magnetoencephalography market across By Application (Clinical ... Read More
-
Active Wheelchair Market Size, Trends, Analysis, and Outlook By Product (Manual Wheelchairs, Power Wheelchairs), By Indication (Alzheimer’s Disease, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis, Diabetes, Cerebral Palsy, Muscular Dystrophy, Parkinson’s Disease, Scoliosis, Spina Bifida, Spinal Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030
... Cord Injury, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Active Wheelchair market size is poised to register 5.04% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Multiple Sclerosis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
2024 Global Forecast for Multiple Sclerosis Therapeutics Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Multiple Sclerosis Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019-2029
... billion by 2029, growing at a CAGR of 3.46% during the forecast period (2024-2029). The COVID-19 pandemic significantly impacted the healthcare systems, affecting not only patients infected with COVID-19 but also others, resulting in disruptions ... Read More
-
Global Multiple Sclerosis (MS) Drugs Market Growth 2024-2030
... downstream market, the Multiple Sclerosis (MS) Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Multiple Sclerosis Drugs Market Growth 2024-2030
... market, the Multiple Sclerosis Drugs is forecast to a readjusted size of US$ 20360 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global ... Read More
-
Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and
... Africa) The global progressive multifocal leukoencephalopathy treatment market is set to experience steady growth from 2024 to 2031. Several key insights are driving this growth in the market: Factors Driving Market Growth: • Rising HIV ... Read More
Research Assistance
